Results 271 to 280 of about 377,160 (316)
Some of the next articles are maybe not open access.

Meeting Report: PDA Virus and TSE Safety Forum

PDA Journal of Pharmaceutical Science and Technology, 2013
The report provides a summary of the presentations and discussions of the Virus & TSE (transmissible spongiform encephalopathy) Safety Forum 2011 that was organized by the Parenteral Drug Association and held in Barcelona, Spain, on 28-30 June, 2011.
Hannelore, Willkommen   +9 more
openaire   +2 more sources

B19 Virus Infection and Blood Safety

Journal of Antivirals & Antiretrovirals, 2015
Human parvovirus B19 (B19) belongs to the family of parvoviridae and viral particle measures 23 nm in diameter. B19 virus has single-stranded DNA genome and is n non-enveloped virus. It is widespread in the world. The virus can be transmitted via respiratory route and blood-derived products in addition to be transmitted vertically from mother to fetus.
openaire   +1 more source

Safety of live‐virus vaccines for children with immune deficiency

Journal of the American Academy of Nurse Practitioners, 2006
AbstractPurpose: Conduct an integrative literature review to evaluate the safety and effectiveness of live‐virus vaccines, namely, the measles, mumps, rubella, and varicella vaccines, in children who are immune compromised by exogenous medication either posttransplant or while undergoing maintenance chemotherapy for leukemia.Data sources: Medline ...
Karlen E, Luthy   +3 more
openaire   +2 more sources

Problem Solved? West Nile Virus and Transfusion Safety

New England Journal of Medicine, 2005
In 2002, just three years after its appearance in the Western Hemisphere, West Nile virus caused the largest outbreak of arboviral encephalitis ever recorded in the United States.1 Epidemiologic investigations that year revealed that West Nile virus could be transmitted by blood transfusion,2 and mathematical models suggested that hundreds of ...
Lyle R, Petersen, Jay S, Epstein
openaire   +2 more sources

Clinical evaluation of virus safety and inhibitor incidence

Blood Coagulation & Fibrinolysis, 1995
The basic statistical issue in pharmacovigilance is to claim, with reasonable certainty, that the incidence of an event of interest in a population of subjects is less than a certain value. How many subjects and events must be observed before such a claim can be made?
M, Buyse, J L, Poplavsky
openaire   +2 more sources

Virus safety of human blood, plasma, and derived products

Thrombosis Research, 2002
The reconstitution of blood and its components is hampered by factors of compatibility, availability, and the risk of transmission of infectious diseases. Protozoal agents such as plasmodium malariae and trypanosoma cruzi are only regionally relevant. Bacterial transmissions are easy to prevent and treat.
openaire   +2 more sources

Current European Regulations for Control of Adventitious Virus Safety

PDA Journal of Pharmaceutical Science and Technology, 2011
CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Michael Wiebe (San Francisco, CA).
openaire   +2 more sources

Postlicensure safety evaluation of human papilloma virus vaccines

International Journal of Risk & Safety in Medicine, 2011
Objective: A summary of postlicensure safety information of HPV vaccines from three sources: VigiBase, the global database of WHO's Programme for International Drug Monitoring, the VAERS report on Gardasil® and the RIVM report on Cervarix®. Method: all AEFI from the three sources were recalculated to a percentage of all AEFI reported for each of the ...
openaire   +2 more sources

HIV ANTIGEN AND VIRUS-SAFETY STUDIES

The Lancet, 1988
A. Ghirardini   +6 more
openaire   +2 more sources

Virus & TSE safety forum 2008

Biologicals, 2009
James S, Robertson   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy